These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2659900)

  • 61. Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.
    Arditi M; Zhou J; Huang SH; Luckett PM; Marra MN; Kim KS
    Infect Immun; 1994 Sep; 62(9):3930-6. PubMed ID: 8063410
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS.
    Dedrick RL; Conlon PJ
    Infect Immun; 1995 Apr; 63(4):1362-8. PubMed ID: 7890395
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum cytokines in patients with rheumatoid arthritis. Correlation of interferon gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells.
    Sakito S; Ueki Y; Eguchi K; Kawabe Y; Nagataki S
    Rheumatol Int; 1995; 15(1):31-7. PubMed ID: 7652463
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation.
    Pugin J; Ulevitch RJ; Tobias PS
    J Exp Med; 1993 Dec; 178(6):2193-200. PubMed ID: 7504060
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.
    Mathison JC; Virca GD; Wolfson E; Tobias PS; Glaser K; Ulevitch RJ
    J Clin Invest; 1990 Apr; 85(4):1108-18. PubMed ID: 2318968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.
    Kovach NL; Yee E; Munford RS; Raetz CR; Harlan JM
    J Exp Med; 1990 Jul; 172(1):77-84. PubMed ID: 2193101
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE; Weiss J; Doerfler ME; Elsbach P
    J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytokine production in whole blood ex vivo.
    Finch-Arietta MB; Cochran FR
    Agents Actions; 1991 Sep; 34(1-2):49-52. PubMed ID: 1793050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood.
    DeForge LE; Tracey DE; Kenney JS; Remick DG
    Am J Pathol; 1992 May; 140(5):1045-54. PubMed ID: 1533750
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood.
    DeForge LE; Fantone JC; Kenney JS; Remick DG
    J Clin Invest; 1992 Nov; 90(5):2123-9. PubMed ID: 1331181
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Production of human tumor necrosis factor from whole blood ex vivo.
    Desch CE; Kovach NL; Present W; Broyles C; Harlan JM
    Lymphokine Res; 1989; 8(2):141-6. PubMed ID: 2659900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Daily production of human tumor necrosis factor in lipopolysaccharide (LPS)-stimulated ex vivo blood culture assays.
    Aguillón JC; Escobar A; Ferreira V; Aguirre A; Ferreira L; Molina MC; Ferreira A
    Eur Cytokine Netw; 2001 Mar; 12(1):105-10. PubMed ID: 11282553
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Modulation of blood cell activation by four commonly used anticoagulants.
    Engstad CS; Gutteberg TJ; Osterud B
    Thromb Haemost; 1997 Apr; 77(4):690-6. PubMed ID: 9134644
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced glucocorticoid sensitivity of monocyte interleukin-6 release in male employees with high plasma levels of tumor necrosis factor-alpha.
    Wirtz PH; von Känel R; Kunz-Ebrecht S; Ehlert U; Fischer JE
    Life Sci; 2004 May; 75(1):1-10. PubMed ID: 15102517
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.